拓邦股份2025年半年度报告(英文版)

Full Text of the Semi-annual Report 2025 of Shenzhen Topband Co., Ltd.1Semi-annualReport 2025Shenzhen Topband Co., Ltd.Stock codeAugust 2025Full Text of the Semi-annual Report 2025 of Shenzhen Topband Co., Ltd.2Semi-annual Report 2025Section I Important Notes, Contents and DefinitionsThe Board of Directors, the Board of Supervisors and directors, supervisors and seniorexecutives of the Company hereby assure that the content set out in the semi-annual report is true,accurate and complete. It shall be free from false records, misleading statements or majoromissions, and shall bear individual and joint legal liabilities therein.Wu Yongqiang, Chairman of the Company, and Luo Muchen, head of accounting and theaccounting department, hereby declare that: the data disclosed in financial reports of the semi-annual report is true, accurate and complete.All directors have attended the Board Meeting at which this Semi-annual Report wasscrutinized.Forward-looking statements such as future plans and development strategies covered in theReport involve uncertainty, so they do not represent the Company's profit forecasts, nor are theyregarded as the substantive commitment to investors.The Company is not faced with significant risks affecting its financial position andsustainable profitability, but may be with such risks as adverse effects on business confidence andinvestment due to trade frictions and geopolitical tensions, technology upgrading, fluctuations inthe prices of raw materials, fluctuations in exchange rates, and customer credit risks. For moredetailed risk information, please see "Risks faced by the Company and countermeasures" inSection III of the Report. Investors are kindly requested to be alert to investment risks.The Company plans not to pay cash dividend, to issue bonus shares, or to increase the sharecapital by capital reserve.The Report is prepared in Chinese and translated into English. Should there be anydiscrepancies or misunderstandings between the two versions, the Chinese version shall prevail.Full Text of the Semi-annual Report 2025 of Shenzhen Topband Co., Ltd.3ContentsSection I Important Notes, Contents and Definitions.....................................................................2Section II Company Profile and Primary Financial Indicators.................................................... 6Section III Management Discussion and Analysis........................................................................10Section IV Corporate Governance, Environment and Society....................................................30Section V Important Matters..........................................................................................................35Section VI Share Change and Shareholders................................................................................. 42Section VII Information on Bonds................................................................................................. 49Section VIII Financial Repor

立即下载
综合
2025-09-23
219页
1.38M
收藏
分享

拓邦股份2025年半年度报告(英文版),点击即可下载。报告格式为PDF,大小1.38M,页数219页,欢迎下载。

本报告共219页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
本报告共219页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
水滴研报所有报告均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
相关图表
表1 医药生物板块上周个股涨跌幅情况
综合
2025-09-22
来源:医药生物行业周报:医保调整,集采优化,持续看好药械板块投资机会
查看原文
图7 医药生物子板块 PE 估值(TTM,剔除负值)
综合
2025-09-22
来源:医药生物行业周报:医保调整,集采优化,持续看好药械板块投资机会
查看原文
图6 申万一级行业 PE 估值(TTM,剔除负值)
综合
2025-09-22
来源:医药生物行业周报:医保调整,集采优化,持续看好药械板块投资机会
查看原文
图5 医药生物板块估值水平及相对估值溢价(TTM,剔除负值)
综合
2025-09-22
来源:医药生物行业周报:医保调整,集采优化,持续看好药械板块投资机会
查看原文
图4 年初至今医药生物子板块涨跌幅
综合
2025-09-22
来源:医药生物行业周报:医保调整,集采优化,持续看好药械板块投资机会
查看原文
图3 年初至今申万一级行业指数涨跌幅
综合
2025-09-22
来源:医药生物行业周报:医保调整,集采优化,持续看好药械板块投资机会
查看原文
回顶部
报告群
公众号
小程序
在线客服
收起